Katharine Knobil - 08 Dec 2021 Form 3 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Issuer symbol
MRKR
Transactions as of
08 Dec 2021
Net transactions value
$0
Form type
3
Filing time
09 Dec 2021, 16:18:18 UTC
Previous filing
15 Jun 2021
Next filing
11 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRKR Common Stock 1,500 08 Dec 2021 see footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by the spouse of the Reporting Person, who shares voting and investment control of the shares and may be deemed to beneficially own the shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of her pecuniary interest therein.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney